Invention Application
- Patent Title: ANTI-ERBB3 ANTIBODIES
- Patent Title (中): 抗ERBB3抗体
-
Application No.: US13082852Application Date: 2011-04-08
-
Publication No.: US20110256154A1Publication Date: 2011-10-20
- Inventor: Sylvie Vincent , William M. Winston, JR. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Botega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
- Applicant: Sylvie Vincent , William M. Winston, JR. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Botega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07H21/00 ; C12P21/00 ; C12N15/63 ; C12N1/00 ; C12N5/10 ; C07K16/28 ; A61P35/00
Abstract:
Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.
Public/Granted literature
- US08481687B2 Anti-ErbB3 antibodies Public/Granted day:2013-07-09
Information query
